Announcements Trials
Browse Landscape

Status

Recruiting 7Completed 2Suspended 1Enrolling by invitation 1Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Lymphoma, Non-Hodgkin 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma 1Leukemia 1

Interventions

Methods 2Interviews as Topic 2Educational Status 2Early Intervention, Educational 2Counseling 2sacituzumab govitecan 1pembrolizumab 1ibrutinib 1futibatinib 1erdafitinib 1enfortumab vedotin 1durvalumab 1avelumab 1Vinblastine 1Tramadol 1Surveys and Questionnaires 1Surgical Procedures, Operative 1Standard of Care 1Specimen Handling 1Robotic Surgical Procedures 1Relaxation Therapy 1Radiotherapy, Adjuvant 1Pregabalin 1Practice Guidelines as Topic 1Platinum Compounds 1Photochemotherapy 1Patient Navigation 1Palliative Care 1Paclitaxel 1Nivolumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Enrolling by invitation × Leukapheresis × 30 days × Clear all
NCT03226704 2026-05-20

Leukapheresis for CAR or Adoptive Cell Therapy Manufacturing

National Institutes of Health Clinical Center (CC)

Enrolling by invitation
120 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Lymphoma, Non-Hodgkin, Lymphoma, Large B-Cell, Diffuse, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡